BiotechTube

Placebo + SIM

Phase 2Terminated
1 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Liver Fibrosis Due to NASH

Conditions

Liver Fibrosis Due to NASH

Trial Timeline

Oct 29, 2012 → Jan 3, 2017

NCT ID
NCT01672879

About Placebo + SIM

Placebo + SIM is a phase 2 stage product being developed by Gilead Sciences for Liver Fibrosis Due to NASH. The current trial status is terminated. This product is registered under clinical trial identifier NCT01672879. Target conditions include Liver Fibrosis Due to NASH.

What happened to similar drugs?

20 of 20 similar drugs in Liver Fibrosis Due to NASH were approved

Approved (20) Terminated (3) Active (0)
✅Advagraf + Prograf + PrografAstellas PharmaApproved
✅Prograf + AdvagrafAstellas PharmaApproved
✅ADVAGRAF®Astellas PharmaApproved
✅Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
✅Advagraf + PrografAstellas PharmaApproved
✅ADVAGRAF®Astellas PharmaApproved
✅tacrolimus + mycophenolate mofetil + PrednisoneAstellas PharmaApproved

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01672866Phase 2Terminated
NCT01672879Phase 2Terminated

Competing Products

20 competing products in Liver Fibrosis Due to NASH

See all competitors
ProductCompanyStageHype Score
LanifibranorInventivaPhase 2
29
GODEX + PlaceboCelltrionPhase 3
47
peginterferon alfa-2a 180μg + peginterferon alfa-2a 90μg + ribavirinChugai PharmaceuticalPhase 3
40
exatecan mesylateDaiichi SankyoPhase 2
35
TacrolimusAstellas PharmaPre-clinical
26
ATG (Fresenius Biotech)Astellas PharmaPhase 2
27
Advagraf + Prograf + PrografAstellas PharmaApproved
43
Prograf + AdvagrafAstellas PharmaApproved
43
ADVAGRAF®Astellas PharmaApproved
43
Prograf + MR4Astellas PharmaPhase 3
40
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
35
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
35
tacrolimusAstellas PharmaPhase 3
40
Prograf-XL + Prograf + MMFAstellas PharmaPhase 3
40
micafungin + fluconazole + liposomal amphotericin B + caspofunginAstellas PharmaPhase 3
40
Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
43
FK506E (modified release tacrolimus) + Prograf (tacrolimus)Astellas PharmaPhase 3
40
FK778Astellas PharmaPhase 2
35
Tacrolimus modified-release + PrografAstellas PharmaPhase 3
40
Advagraf + PrografAstellas PharmaApproved
39